A summary of the new GINA strategy : a roadmap to asthma control
Copyright ©ERS 2015..
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA report was published in 2014, and updated in 2015, reflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted treatment, and evidence about effective implementation approaches. During development of the report, the clinical utility of recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence.This article provides a summary of key changes in the GINA report, and their rationale. The changes include a revised asthma definition; tools for assessing symptom control and risk factors for adverse outcomes; expanded indications for inhaled corticosteroid therapy; a framework for targeted treatment based on phenotype, modifiable risk factors, patient preference, and practical issues; optimisation of medication effectiveness by addressing inhaler technique and adherence; revised recommendations about written asthma action plans; diagnosis and initial treatment of the asthma-chronic obstructive pulmonary disease overlap syndrome; diagnosis in wheezing pre-school children; and updated strategies for adaptation and implementation of GINA recommendations.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
The European respiratory journal - 46(2015), 3 vom: 14. Sept., Seite 622-39 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Reddel, Helen K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adrenal Cortex Hormones |
|---|
| Anmerkungen: |
Date Completed 03.06.2016 Date Revised 23.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1183/13993003.00853-2015 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM251193071 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM251193071 | ||
| 003 | DE-627 | ||
| 005 | 20240323233751.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1183/13993003.00853-2015 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1342.xml |
| 035 | |a (DE-627)NLM251193071 | ||
| 035 | |a (NLM)26206872 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Reddel, Helen K |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A summary of the new GINA strategy |b a roadmap to asthma control |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2016 | ||
| 500 | |a Date Revised 23.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright ©ERS 2015. | ||
| 520 | |a Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA report was published in 2014, and updated in 2015, reflecting an evolving understanding of heterogeneous airways disease, a broader evidence base, increasing interest in targeted treatment, and evidence about effective implementation approaches. During development of the report, the clinical utility of recommendations and strategies for their practical implementation were considered in parallel with the scientific evidence.This article provides a summary of key changes in the GINA report, and their rationale. The changes include a revised asthma definition; tools for assessing symptom control and risk factors for adverse outcomes; expanded indications for inhaled corticosteroid therapy; a framework for targeted treatment based on phenotype, modifiable risk factors, patient preference, and practical issues; optimisation of medication effectiveness by addressing inhaler technique and adherence; revised recommendations about written asthma action plans; diagnosis and initial treatment of the asthma-chronic obstructive pulmonary disease overlap syndrome; diagnosis in wheezing pre-school children; and updated strategies for adaptation and implementation of GINA recommendations | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
| 650 | 7 | |a Anti-Asthmatic Agents |2 NLM | |
| 700 | 1 | |a Bateman, Eric D |e verfasserin |4 aut | |
| 700 | 1 | |a Becker, Allan |e verfasserin |4 aut | |
| 700 | 1 | |a Boulet, Louis-Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Cruz, Alvaro A |e verfasserin |4 aut | |
| 700 | 1 | |a Drazen, Jeffrey M |e verfasserin |4 aut | |
| 700 | 1 | |a Haahtela, Tari |e verfasserin |4 aut | |
| 700 | 1 | |a Hurd, Suzanne S |e verfasserin |4 aut | |
| 700 | 1 | |a Inoue, Hiromasa |e verfasserin |4 aut | |
| 700 | 1 | |a de Jongste, Johan C |e verfasserin |4 aut | |
| 700 | 1 | |a Lemanske, Robert F |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Levy, Mark L |e verfasserin |4 aut | |
| 700 | 1 | |a O'Byrne, Paul M |e verfasserin |4 aut | |
| 700 | 1 | |a Paggiaro, Pierluigi |e verfasserin |4 aut | |
| 700 | 1 | |a Pedersen, Soren E |e verfasserin |4 aut | |
| 700 | 1 | |a Pizzichini, Emilio |e verfasserin |4 aut | |
| 700 | 1 | |a Soto-Quiroz, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Szefler, Stanley J |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Gary W K |e verfasserin |4 aut | |
| 700 | 1 | |a FitzGerald, J Mark |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The European respiratory journal |d 1989 |g 46(2015), 3 vom: 14. Sept., Seite 622-39 |w (DE-627)NLM012664782 |x 1399-3003 |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2015 |g number:3 |g day:14 |g month:09 |g pages:622-39 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1183/13993003.00853-2015 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2015 |e 3 |b 14 |c 09 |h 622-39 | ||